Özet:

The aim of this study is to evaluate the prevalence of metabolic syndrome and its components in postmenopausal patients and their connection to hormonal changes in literature. Methods: Medical records of 138 postmenopausal patients were examined retrospectively between January and March 2014. Patients with surgical menopause, hormone replacement therapy, chemotherapy and radiotherapy were not included in the study. In the diagnosis of metabolic syndrome, the National Cholesterol Training Program Adult Therapy Panel III (NCEP-ATP III) diagnostic criteria were used. Demographic information of patients, menopause status, medical history, physical examination and clinical laboratory data were questioned. The data was statistically assessed. The study included 128 patients. Menopause age was 50,06±2,93 in patients with metabolic syndrome and 45,16±4,4 in patients with non-metabolic syndrome. In our study, the rate of metabolic syndrome was 43.4%. A statistically meaningful high coleration between the back circle and the number of metabolic components and the FSH-LH level was detected in the negative direction (p<0,05). The result: the prevalence of metabolic syndrome in postmenopausal women is high, abdominal obesity and low levels of HDL are strong predictor factors. These factors can lead to an increase in cardiovascular diseases. By encouraging lifestyle changes, the rate of metabolic syndrome can be reduced. (JAREM 2016; 6: 35-9)

Anahtar Kelimeler: